125 related articles for article (PubMed ID: 24211883)
1. A novel liposomal nanomedicine for nitric oxide delivery and breast cancer treatment.
Lee SY; Rim Y; McPherson DD; Huang SL; Kim H
Biomed Mater Eng; 2014; 24(1):61-7. PubMed ID: 24211883
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia.
Huang SL; Kee PH; Kim H; Moody MR; Chrzanowski SM; Macdonald RC; McPherson DD
J Am Coll Cardiol; 2009 Aug; 54(7):652-9. PubMed ID: 19660697
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
4. Improvement of cytotoxic and apoptogenic properties of crocin in cancer cell lines by its nanoliposomal form.
Mousavi SH; Moallem SA; Mehri S; Shahsavand S; Nassirli H; Malaekeh-Nikouei B
Pharm Biol; 2011 Oct; 49(10):1039-45. PubMed ID: 21936628
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-loaded echogenic liposomes for treatment of vasospasm following subarachnoid hemorrhage.
Kim H; Britton GL; Peng T; Holland CK; McPherson DD; Huang SL
Int J Nanomedicine; 2014; 9():155-65. PubMed ID: 24379666
[TBL] [Abstract][Full Text] [Related]
6. Liposomal modular complexes for simultaneous targeted delivery of bioactive gases and therapeutics.
Klegerman ME; Wassler M; Huang SL; Zou Y; Kim H; Shelat HS; Holland CK; Geng YJ; McPherson DD
J Control Release; 2010 Mar; 142(3):326-31. PubMed ID: 19903503
[TBL] [Abstract][Full Text] [Related]
7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
8. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
9. A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells.
Huang Y; Hager ER; Phillips DL; Dunn VR; Hacker A; Frydman B; Kink JA; Valasinas AL; Reddy VK; Marton LJ; Casero RA; Davidson NE
Clin Cancer Res; 2003 Jul; 9(7):2769-77. PubMed ID: 12855657
[TBL] [Abstract][Full Text] [Related]
10. Death receptor-dependent and -independent pathways in anticancer drug-induced apoptosis of breast cancer cells.
Kim R; Tanabe K; Emi M; Uchida Y; Toge T
Oncol Rep; 2003; 10(6):1925-30. PubMed ID: 14534720
[TBL] [Abstract][Full Text] [Related]
11. Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.
Cheema SK; Gobin AS; Rhea R; Lopez-Berestein G; Newman RA; Mathur AB
Int J Pharm; 2007 Aug; 341(1-2):221-9. PubMed ID: 17499461
[TBL] [Abstract][Full Text] [Related]
12. Co-Delivery of Therapeutics and Bioactive Gas Using a Novel Liposomal Platform for Enhanced Treatment of Acute Arterial Injury.
Huang SL; Moody MR; Yin X; McPherson DD; Kim H
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238730
[TBL] [Abstract][Full Text] [Related]
13. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
Liu Y; Lu WL; Guo J; Du J; Li T; Wu JW; Wang GL; Wang JC; Zhang X; Zhang Q
J Control Release; 2008 Jul; 129(1):18-25. PubMed ID: 18466993
[TBL] [Abstract][Full Text] [Related]
14. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
Shroff K; Kokkoli E
Langmuir; 2012 Mar; 28(10):4729-36. PubMed ID: 22268611
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide improves molecular imaging of inflammatory atheroma using targeted echogenic immunoliposomes.
Kim H; Kee PH; Rim Y; Moody MR; Klegerman ME; Vela D; Huang SL; McPherson DD; Laing ST
Atherosclerosis; 2013 Dec; 231(2):252-60. PubMed ID: 24267236
[TBL] [Abstract][Full Text] [Related]
16. Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells.
Stover T; Kester M
J Pharmacol Exp Ther; 2003 Nov; 307(2):468-75. PubMed ID: 12975495
[TBL] [Abstract][Full Text] [Related]
17. Stability of echogenic liposomes as a blood pool ultrasound contrast agent in a physiologic flow phantom.
Radhakrishnan K; Haworth KJ; Huang SL; Klegerman ME; McPherson DD; Holland CK
Ultrasound Med Biol; 2012 Nov; 38(11):1970-81. PubMed ID: 22929652
[TBL] [Abstract][Full Text] [Related]
18. Liposomal nanomedicine for breast cancer therapy.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
Nanomedicine (Lond); 2011 Aug; 6(6):1085-100. PubMed ID: 21955078
[TBL] [Abstract][Full Text] [Related]
19. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
Shahin M; Soudy R; El-Sikhry H; Seubert JM; Kaur K; Lavasanifar A
Cancer Lett; 2013 Jul; 334(2):284-92. PubMed ID: 23073474
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
